Clinical Trial Update: Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating androgen deprivation therapy and vorinostat followed by radical prostatectomy in localized prostate cancer shows completed status wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• Vorinostat (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Adenocarcinoma, Stage I Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-10-06